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Drug delivery systems (DDS) allow for precise control of the concentration of a drug in 
the organism over space and/or time. If loaded with the drugs before implantation, DDS 
could be engineered to release the drug under external stimulus. This stimulus could be 
light at 980nm which can penetrate the skin. This biophotonic DDS could then fight 
infections locally. Such DDS need to be fabricated from bioactive glasses which react 
when pumped at 980nm. Such glasses are capable of firm bonding with the surrounding 
tissues by developing bone-like hydroxyapatite (HA) layers when reacting with 
physiological fluids.  
This thesis is focused on the development of the glass which will be used for the 
fabrication of the DDS: The glass of investigation is glass S53P4 (commercially available 
as BonAlive®) derivative from 50% SiO2 substitution (B50), which shows a faster 
dissolution, and faster conversion into HA than S53P4 glass. Er3+ & Yb3+ ions and 
NaYF4:Er3+,Yb3+ nanocrystals (NCs) were added in the bioactive glass so it can exhibit 
upconversion luminescence properties under 980nm pumping.  
The development of upconverting glasses with the possibility to be sintered into highly 
porous scaffolds with high upconversion is first discussed. The glasses with the 
composition 95.5B50-0.5Er2O3-4Yb2O3 (in mole %) and with the composition 98%B50-
2% NaYF4:Er3+,Yb3+ (wt.%) were found to be the most promising glasses for the 
fabrication of the scaffolds which are not only bioactive but also exhibit green light under 
980nm pumping. Scaffolds were processed using the burn off method. They possess the 
appropriate level of porosity and exhibit upconversion. However, crystallization occurred 
during the sintering leading to some changes in the shape and intensity of the 
upconversion. The mechanical properties of the modified scaffolds were comparable to 
those of the B50 scaffold. 
Scaffolds with 60-75% porosity were immersed in SBF for up to 336h. We found that 
they have a slower dissolution rate than the base glass but maintained an acceptable 
dissolution rate. The possibility to use the developed scaffolds in DDS using external 
near infrared excitation as a control signal is finally discussed in this thesis. 
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1. INTRODUCTION & OBJECTIVES 
Together with the development of medical science, biology and engineering, there has 
always been an interest of merging their knowledge to create new methods and materials 
to improve medical treatments and reduce their complications. To improve live conditions 
of humans, various materials are being researched and innovated to be used in medi-
cine. One of the main current focuses of research is biomaterials, which have been de-
fined by Williams as “A biomaterial is a substance that has been engineered to take a 
form which, alone or as part of a complex system, is used to direct, by control of interac-
tions with components of living systems, the course of any therapeutic or diagnostic pro-
cedure, in human or veterinary medicine” [Wi,09] 
Biomaterials are a big topic that can be further classified depending on both their origin 
and their interaction with the body: i) bioactive materials: they can form a chemical bond-
ing with the surrounding tissue; ii) bioinert materials: they don’t react with the body, and 
iii) biotolerant materials: they are encapsulated by conjunctive tissue layer. This thesis 
focuses on the development of inorganic bioactive materials, specifically, on bioactive 
glasses. Bioactive glasses have been previously defined as a subset of the inorganic 
bioactive materials that is capable of reacting with physiological fluids to form firm bonds 
to bone through the development of hydroxy apatite (HA) layers, a main constituent of 
bone, as well as providing a proper surface interaction to collagen [He,71]. Since the 
creation of the first bioactive glass (Bioglass©) in 1969 by Larry Hench [He,71], research 
on bioactive glasses has grown exponentially, and novel glass compositions, manufac-
turing techniques and structures have been developed. Other alternatives have been 
tried to mix bioactive materials and photonics [Do,09]. However, not much research has 
been performed with the aim to combine this research with the photonics field. Biopho-
tonics field has several promising qualities for the development of devices that can com-
municate fast and without invasive surgery. The device can be engineered to operate in 
a spectral range where the body is transparent to the signal, allowing external commu-
nication at the speed of light. In order to maximize the utility of the properties that pho-
tonics can provide, a drug delivery system was envisioned, that can be placed in a 
dormant state inside the host during a surgery as a substitute to the damaged tissue, but 
in case of detected infection, it can rapidly be activated and modulated to fight against it. 
Before 1950, all drugs were made into either a capsule or a pill to release their loading 
immediately after contacting water, without any kind of control on the kinetics of the re-
lease [Yu,15]. In 1952, Smith Klein Beecham created the first controlled delivery, achiev-
ing a twelve hours long efficacy of the drug [Le,10]. During the first generation of drug 
delivery systems (DDS) (developed between 1950 & 1980), the different systems only 
allowed for a controlled or retarded release of the drug. Second generation (1980-2010), 
had a lower success rate in releasing products to the market, and suffered from an initial 
release spike during the first days, releasing almost of the drug, even if the effects were 
supposed to last for a couple months. Also, second generation suffered from problems 
in dealing with targeted treatments for tumoral cell using nanoparticles, which have not 
yet been successful. The third generation, which started in 2010, has tried to solve all 
the previous issues and found either long term release (several months between external 
dosage, targeted treatment or externally controlled dosage) [Yu,15]. 
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This thesis focusses on the development of a new generation of DDS from newly engi-
neered biophotonics glass-based scaffolds for drug release using external near infrared 
excitation as a control signal. 
The main content of this thesis is divided into four different parts. First, in chapter two, a 
background introduction of the required fields for the understanding of this work is pre-
sented. General concepts in glass science, biomaterials, scaffolds and drug delivery sys-
tems is provided. A deeper insight to the specific areas of photonic and bioactive glasses, 
as well as scaffold and drug delivery system production is presented. This document 
follows with chapter three; whose purpose is to present and explain the methodology 
carried out during the experimental part of this thesis, along with explaining the preestab-
lished knowledge about the main materials used during this thesis. To continue, chapter 
four describes the results obtained from the experimental procedures carried out during 
the development of the work, in addition to discussing the meanings and implications 
these results have. This chapter is divided into two different sections: 1) the production 
of the glasses, and sintering of the scaffolds are explained together with their mechanical 
and optical characterization and 2) the bio-and photo-response of the materials is ana-
lyzed. Finally, chapter five summarized the main conclusions obtained from this study 
and lists also the next steps which should be followed in order to properly supplement 
and continue this work. 
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2. THEORETICAL BACKGROUND 
2.1 Glass 
Glasses are a group of materials characterized by having amorphous solid state (lack of 
long-range order) and a glass transition temperature (Tg).(Shelby 2005). The glass tran-
sition temperature of a glass is the temperature under which the material stops behaving 
as a liquid while still not crystallizing after a fast-enough cooling.  
The process of glass forming from a liquid is called vitrification and this process is based 
on the reduction of the available energy and time for the material, locking it into a meta-
stable state. 
A glass is made by up to five different components: glass former ions, network modifiers, 
intermediate oxides, dopants and impurities. (Shelby 2005) 
▪ Glass former ions are responsible for the creation of the backbone of the glass. 
This group includes SiO2, P2O5 & B2O3 just to cite a few and they create a network by 
joining the cations with bridging oxygens. 
▪ Network modifiers are responsible to open and disrupt the network increasing 
the free volume. These component bond ionically to the bridging oxygens transforming 
them into non-bridging oxygens. Examples of these components are alkaline or alkaline-
earth metal oxides. (Na2O, K2O, CaO, …). 
▪ Intermediate oxides are components that contribute in the formation of the net-
work but cannot create a glass network by themselves. Example of these components 
are Al2O3, TiO2 & ZnO. 
▪ Dopants are components which do not change the glass structure when intro-
duced in few mol%. They sit in the free volume and are added to the glass to alter some 
of its properties. Some examples are Ag2O or rare-earth ions such as Er2O3, Yb2O3. 
▪ Impurities are components not desired in the glass and so they may alter some 
of the glass properties. Examples are contamination from the production process such 
as the crucible, furnace or the impurities from the raw materials and water (OH groups).  
Glass materials are known since ancient times as the first glass production can be 
tracked back into 2500BC in Syria. The production was extended into other nearby civi-
lizations of the time such as Mesopotamia and Egypt before spreading worldwide. But 
glasses are not just artificially made materials as vitreous materials can also be found in 
nature, such as obsidian, an igneous rock made by the fast cooling of lava from volca-
noes. [Ru,19] 
Glasses are known to be strongly affected by small alterations in their production due to 
their intrinsic metastable nature, as they don’t relax to a minimum energy disposition 
(crystal) but are “frozen” into a midpoint while trying to adapt. The specific midpoint they 
are stuck into is determined by all the glass history. 
Nowadays glass materials are used in multiple applications such as packaging, housing, 
automotive, electronics and energy production as well as photonics and medical tech-
nology, disciplines deeply related to the topic of this document. 
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2.1.1 Photonic glasses 
Photonics is dealing with the photon generation and detection, as well as stimulated 
emission, photon frequency conversion and polarization change. This branch of science 
was born with the invention of the ruby laser in 1960, and the Photonics word was first 
used in 9th International Symposium on High Speed Photograph in 1970, when it was 
defined as “a systematic science concerning the photon as the information carrier”. 
The development of photonics as well as the related fields of optics and opto-electronics 
still needs to explore new materials, in which glassy or amorphous materials are the 
important ones [Fu,06]. 
Photonic glasses are a branch of optical glasses defined as optically homogeneous 
glass, free from defects. They include several families such as laser glasses, nonlinear 
functional glasses and new photonic glasses (Photo-induced data storage glasses, pho-
tonic crystals, …) 
Laser glasses are glasses doped with laser active rare-earth (RE) ions, highlighted in 
Fig: 2-1.  
 
Figure 2-1: Rare earths elements [Mi,20]  
These ions absorb pumped light which excites their electron into metastable levels and 
emit light when they relax by stimulated emission of radiation, an effect where a photon 
stimulates an excited atom to emit a photon coherent (same energy, momentum and 
phase) with the initial one (Fig: 2-2).  
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Figure 2-2: Energy diagram photophysical effects in light amplification by stimulated 
emission of radiation (Laser) [Fi,20]. 
This effect escalates quickly in the proper medium. By a proper control of the medium 
(population inversion, proper confinement of desired photons & elimination of undesired 
photons), a cascade of coherent photons can be created and directed into forming a 
beam. 
As specified, lasing requires a population inversion, this is a key parameter as in order 
to promote stimulated emission over absorption, there is a requirement of having a more 
populated high energy level than ground level, this situation is called population inver-
sion. 
In order to produce large laser effect, a huge interaction between the lasered light and 
the material is required. This is usually obtained by confining the lasered light into a 
specific volume by the use of mirrors. The use of two mirrors, one perfect mirror, and 
one almost perfect one is the most common procedure to obtain laser effect, these mir-
rors are facing each other creating a cavity in between, in which light can bounce repeat-
edly summoning more and more coherent photons, until some of them pass through the 
non-perfect mirror to the outside (laser beam) as shown in Fig: 2-3.  
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Figure 2-3: Schematic of laser emission. [Ki,11] 
One of the advantages of this technique is that only those photons that travel perpendic-
ularly to the mirrors are confined into the cavity, while the rest of them are able to exit 
the cavity without much interaction. Therefore, the efficiency losses from undesired stim-
ulated emission are reduced.  
A particular set of laser glasses are the up-converter laser glasses. In most cases, the 
pumping light has a lower wavelength (higher energy) than the emitted light, but in the 
case of up-converters, the pumping light has lower energy. The stimulation of the atoms 
to a high enough level requires a multiphoton process which is usually obtained by using 
two different RE ions, one with the emission desired level, and a pumping one, whose 
main purpose is to absorb pumping light, and to deliver the high energy electrons to the 
emitting ions. 
This study is centered in the Er-Yb codoping for upconversion. Both rare earths are pre-
sented as their trivalent cations, Er3+ & Yb 3+. This codoping is interesting as it allows for 
near infrared (NIR) to visible light frequency up conversion as shown below.  
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Figure 2-4: Simplified energy level diagram of Er3+/Yb3+ ions. Upwards arrows indicate 
excitation photons and downwards arrows stand for emission photons [Ol,98]. 
The typical upconversion fluorescence spectrum of a Er3+:Yb3+ codoped glass under 
≈1μm irradiation show peaks centered around 530, 555, 670, 830, and 925 nm, corre-
sponding to the transition from  2H11/2 , 4S3/2 , 4F9/2 , 4I9/2 , and 4I11/2 excited levels to the 
4I15/2 ground state, respectively [Ol,98]. Previous studies show that codoping with Yb, 
increases Er upconversion efficiency up to 25 times in Ga:La:S chalcogenide glass 
[Ol,98]. 
 
2.1.2 Biomaterials 
Biomaterials have been defined as “any substance or combination of substances, other 
than drugs, synthetic or natural in origin, which can be used for any period of time. They 
can augment or replace partially or totally any tissue, organ or function of the body. They 
are used to maintain or improve the quality of life of the individual’’ by the American 
Institute of Health [Be,13]. In other words, a biomaterial is anything that after having been 
implanted in a body, it substitutes or even helps in the recovering of any tissue, organ or 
body function.  
Materials for biological applications have since been classified depending on the reaction 
of the surrounding tissue, and the interface between the tissue and the material over 
time. This classification is as follows: 
- Non-biocompatible materials which are composed of cytotoxic materials. This 
group encompasses materials that kill their surrounding tissue. Examples of substances 
in this group are Pb or As. There are also carcinogenic materials, which don’t kill the 
surrounding tissue but promote the growth of tumors, substances such as Cd or Ben-
zene, belong to this group. 
- Biocompatible materials which are composed of different biocompatible materi-
als which are schemed in Fig: 2-5 
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Figure 2-5: Scheme of different biocompatibility degrees: 
 biotolerance (a), bioinertness (b) bioactivity (c) 
Biotolerant materials promote the development of a conjunctive tissue layer between 
the material and the rest of the body. This “capsule” remains after the recovery from the 
wounds coming from the implantation, acting as a barrier isolating the foreign material. 
Most of the materials historically used for biomedical applications, such as stainless 
steel, are part of this group. 
Bioinert materials don’t show any kind of reaction from the body after the initial recov-
ery, or the response is too little to be significant. Titanium is a bioinert material. 
Bioactive materials promote a desired controlled response from the surrounding tissue. 
They usually show properties such as biosorption and osseointegration. The materials 
in this group can further be classified into two subclasses: class A promotes bone in-
growth where the bone was not present, while class B promotes interface bone-implant. 
The use of biomaterials goes back to ancient Egypt and Rome, and were based on using 
metals such as gold or materials from organic sources such as wood, ivory or animal 
sinew [NI,20]. In the 20th century, polymethyl methacrylate (PMMA) was introduced to 
the list as the first polymer and the first synthetic biomaterial. The field has developed 
significantly since. Initially, metals such as Titanium seemed to be the best material for 
the application, due to its outstanding mechanical properties. However, uncoated metals, 
even when non-toxic, exhibit a bioinert or biotolerant behavior, not allowing for deep 
continuous integration with the surrounding tissue (biointegration) [Be,13]. Therefore, 
ceramics have emerged as promising candidates as they allow cell ingrowth [Be,13]. 
 
2.1.3 Bioactive glasses 
Bioactive glasses are osteoconductive and osteoinductive materials that have been de-
fined as materials that undergo specific surface reactions leading to the formation of a 
hydroxyapatite (HA) like layer after implantation in the body. HA is a phosphate mineral 
with specific stoichiometry (Ca10(PO4)6(OH)2). Nevertheless, it can generally include any 
apatite calcium phosphate with major structural and compositional characteristics of HA, 
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usually deviating from stoichiometric composition [Hu,06]. The HA-like layer forms a 
bond to both soft and hard tissues simultaneously [Ko,06]. The capability of forming this 
HA-like layer after immersion in simulated body fluid (SBF) in vitro is often taken as an 
indication of the bioactivity response of a material [Ko,90]. Additionally, this in vitro bio-
activity has been suggested as an indication of the material’s potential bioactivity in vivo 
[He,71] [He,91] [Ra,11].  
In an ideal situation the decomposition rate of the glass equals the regeneration rate of 
the surrounding tissue, providing enough support while not permanently remaining in the 
body [Jo,15]. A bioactive glass, when implanted is expected to completely dissolve while 
promoting bone growth, but this statement doesn’t always hold true, as there has been 
evidence of glass remnants years after implantation [Li,10] . 
There are several types of bioactive glasses, from convectional silicate glasses, such as 
Bioglass, to newer kinds such as phosphate and borate-based glasses. Recently the 
interest on borosilicate glasses has increased due to their exceptional behavior in the 
treatment of chronic wounds, such as ulcers [Fu,10]. On the other hand, phosphate 
glasses benefit for fast solubility [Ro,18]. 
 
2.2 Bioactive scaffolds 
Porous scaffolds in tissue engineering play an important role in controlling cell function 
and guiding new organ formation [Ch,02]. A scaffold is in essence a 3D temporary struc-
ture to which isolated and expanded cells adhere in all three dimensions (Fig: 2-6). A 
structure where the cell can proliferate, and secrete their own extracellular matrices, 
replacing the biodegrading scaffold [Ch,02]. 
 
Figure 2-6: Microstructures of bioactive glass scaffolds created by a variety of pro-
cessing methods [Ra,11] 
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Significant challenges to this approach include the design and fabrication of the scaf-
folds. 
 
2.2.1 Materials used for the fabrication of scaffolds  
Several different materials have been tested for the fabrication of solid scaffolds and they 
can be grouped into three different categories: Linear aliphatic polyesters, natural mac-
romolecules and inorganic materials. 
Linear aliphatic polyesters: Polylactic acid (PLA), polyglycolic acid (PGA) and their 
copolymers (PLGA), are the most used family of aliphatic polyesters in tissue engineer-
ing. These polymers degrade in the body by hydrolysis of their ester bonds. PGA has a 
very fast degradation rate (loss of mechanical stability between two and four weeks), 
while the more hydrophobic PLA degrades slower (mechanical integrity lost in several 
months or even years) [Ma,04]. PLGA are among the few approved by the American 
Food and Drug Administration (FDA) for certain human clinical applications. Other used 
aliphatic polyesters are poly ε-caprolactone (PCL) and poly hydroxy butyrate (PHB) 
whose degradation rates are even slower than PLA making them less interesting for 
tissue engineering applications, but more attractive for long term implants and controlled 
release applications [Ma,04]. 
Natural macromolecules, such as proteins and polysaccharides, have also been used 
for tissue engineering. Collagen is a fibrous protein that is a major component in the 
extracellular matrix. This protein has been widely used for soft tissue repair and copoly-
merized into collagen-glycosaminoglycan (CGAG) to fabricate scaffolds for tissue engi-
neering. Denaturalized collagen (Gelatin) has also been processed into porous materials 
for tissue repair. In the other hand, collagen presents some issues such as potential 
pathogen transmission, immune reactions, handling, mechanical properties and less 
controlled biodegradability. Silk is another widely used natural fibrous protein in the field 
of tissue engineering. Silkworm silk shows in vivo degradation from enzymatic mecha-
nism, but the rate is very slow. There are also some concerns over its cytotoxicity. The 
last group of natural materials widely used are polysaccharides. For example, alginate, 
chitosan, and hyaluronate have been used as porous solid-state tissue engineering scaf-
folds. Apart from the relatively pure natural materials, processed extracellular matrix (de-
naturalized) materials with several natural macromolecules are also used as scaffolds 
for tissue engineering or repair, such as internal intestinal submucosa, porcine heart 
valves, or human dermis. Again, there are big concerns about pathogen transmission 
and immune reactions. 
Inorganic materials have also been studied for bone and other mineralized tissue en-
gineering research. Both natural and synthetic inorganic materials have been researched 
in the recent years. Natural inorganic scaffolds such as coral, mineralized silk proteins, 
and antlers possess suitable biocompatibility and osteoconductive properties because 
they are structurally similar to the mineralized tissues in the body. In the other end of the 
spectrum, are the synthetic inorganic materials, these materials are from the ceramic 
family of materials. The most studied among these materials are synthetic hydroxyap-
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atite (HA), Nano HA, Bioglass, Beta Tricalcium Phosphate (βTCP), and Calcium Phos-
phate (CaP) [Ta,12]. The advantages from this type of materials are the lower concern 
about pathogen transmission and immune reactions. However, a less specialized struc-
ture than that of organic materials is their main drawback. Therefore, intense research is 
being conducted to simulate the structure of organic materials with inorganic ones. 
 
2.2.2 Requirement for glass scaffolds and their fabrication process 
Bioactive glasses come in several different forms and sizes, as shown in Fig: 2-7, and 
the specifics of their behavior is dependent on the specific geometry [Yl,00] [Hu,12] 
[Zh,12] [De,12] [Fa,12]. 
 
Figure 2-7 Different bioactive glasses available [Fa,12] 
Different geometries show different pore shape, size and connection as well as glass´ 
specific surface area, changing the characteristics of the contact between the glass and 
the body. For example, higher surface area enhances reactivity and dissolution rate, 
while the porosity requires certain characteristics of minimum pore size and open con-
nectivity to allow tissue ingrowth and neovascularization [Li,07] 
3D Scaffolds have been used to grow cell [Su,04]. To be promising, scaffolds need to 
possess the following properties  
1) Have high porosity (>50%), and proper pore size (~100µm). 
2) High surface area. 
3) Mechanical integrity to maintain the predesign tissue structure. 
4) Biocompatibility and bioactivity  
5) Biodegradability and a proper degradation rate matching the formation of new tis-
sue  
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Different approaches to fabricate bioactive glass has been developed [Fu,11], such as 
electrospinning of a sol-gel to create nanofibers [Hu,12] [De,12], sintering of 
microspheres [Yl,00] or glass powder [Go,01] to achieve highly porous structures, sol-
gel infiltration of polymer foam [Li,07], freeze casting [De,06] or solid free forming [Ho,05] 
[Fu,11 (2)]. 
 
2.2.3 Borosilicate scaffold  
Borate and borosilicate bioactive glasses have been prepared [Ya,07] [Fu,10]. When 
compared to silicate glass, borate bioactive glass was found to degrade faster and com-
pletely convert to HA because of its low chemical durability [Hu,06]. As such, the degra-
dation rate of the glass can be tailored to the desired value by adjusting the SiO2 / B2O3 
ratio, allowing the production of a bioactive glass with a degradation rate matching bone 
regeneration rate [Ra,11]. 
An interesting family of borosilicate glasses is the glass system corresponding to the 
S53P4 bioactive glass system (commercially available as BonAlive®) . These glasses 
adhere to the following composition: (53.85 - x) SiO2 – xB2O3 – 22.66 Na2O – 1.72P2O5 – 
21.77 CaO with x varying from 0 to 53.85 in mol%. These gasses are usually labelled by 
the B2O3 / (SiO2 B2O3) ratio (B0 (S53P4), B25, B50, B75 and B100). These glasses show 
interesting properties, such as moderate glass transition temperature (500<Tg<550ºC) 
and ΔT > 100ºC, indicating that these glasses are stable against crystallization [Ma,12] 
[Oj,16] [Fa,17] [Pr,18]  
Among the glass family, the 50% substitution of SiO2 by B2O3 (B50) was found to exhibit 
the most interesting balance of properties among the family [Oj,16] [Fa,17] [Oj,18], and 
is the focus material of this work. [Oj,18]. The sintering analysis of the borosilicate glass 
was performed by differential thermal analysis, and surface crystallization was found to 
be the main crystallization mechanism. The glass was sintered into porous scaffolds and 
the effect of the particle size and sintering temperature was analyzed. Amorphous scaf-
folds were successfully processed with porosity ranging from 10 to 60% and with com-
pressive strength from 1 to 35MPa. The scaffolds retained their capabilities to rapidly 
create an HA layer with a faster rate than the FDA approved S53P4 bioactive glass 
[Oj,16] [Fa,17]. The cell behavior of the B50 scaffolds was also evaluated. Despite re-
ducing hASC proliferation and inhibiting cell pro, the B50 glass stimulates osteogenic 
commitment and upregulate endothelial markers, thus supporting their further evaluation 
for regenerative medicine [Oj,18]. 
B50 is reported with the following properties [Fa,17] [Oj,16] [Oj,18]: 
- Tg= (510 ± 2) ºC, Tx= (675 ± 2) ºC, Tp= (724 ± 2) ºC & ΔT (Tx-Tg) = (165 ± 4) ºC.  
- Ea= (250 ± 30) kJ/mol, & crystallization speeds of (95±12), (72±11) & (49±2) μm/h 
at Tp – 20, 40 & 60 ºC respectively.  
- Compressive strength of ≈2.5MPa for scaffolds with 50% porosity.  
- Higher dissolution rate than pure silica scaffolds. 
- Comparable osteogenic properties to unmodified S53P4 
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2.3 Drug delivery systems 
Drug delivery systems (DDS) have been designed to improve the pharmacological and 
therapeutic properties of drugs administered parenterally [Al,04]. Their main purpose is 
to control the delivery of a drug either in space, time or in both at the same time.  
In conventional drug delivery, either by oral or intravenous route, the drug spreads along 
the whole body, even if the infected area is highly localized resulting in higher drug dos-
age as well as in potential side effects.  
The use of spatially localized drug release allows only the medication to the afflicted 
zone. This opens the possibilities to use cytotoxic drug which also destroys the surround-
ing tissue when the delivery can be properly controlled. Such localized drug delivery 
systems offer a very promising possibility to treat cancerogenic tumors.[Si,12]. Addition-
ally, the drug concentration profile over time spikes after every dose intake when using 
conventional drug administration, the profile decreasing afterwards. Therefore, this lo-
calized drug release process produces an oscillating value of the concentration that can 
reach both toxicity concentrations as well as ineffective concentration ranges as depicted 
in Fig: 2-8  
 
Figure 2-8:Hypothetical drug concentration profiles in the systemic circulation resulting 
from the consecutive administration of multiple doses of an immediate-release drug de-
livery system (A), A2, • • ) compared to the ideal drug concentration profile (B) required 
for treatment. [Yi,91] 
In Fig: 2-8 we can observe the advantages of the DDSs, where the concentration profile 
can steadily remain in the ideal concentration range, allowing the drug to act all the time, 
while not giving adverse side effects. 
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2.3.1 Localized drug delivery systems 
The DDSs can be classified based on their technical sophistication as shown in Fig: 2-9  
 
Figure 2-9:Classes of DDSs [Yi,91] 
Rate-preprogrammed drug delivery systems encompasses those DDSs in which the 
delivery systems have been preprogrammed at specific rate profiles. This is accom-
plished by system design, which controls the molecular diffusion of drug molecules in, 
and/or across the barrier medium within or surrounding the DDS. In this kind of system, 
Fick´s diffusion laws are usually followed. Release rate and profile are obtained by 
choosing the optimal capsule materials and geometry [Yi,91]. 
Activation-modulated drug delivery systems encompasses those DDSs in which the 
release of drug molecules from the DDS is activated by some physical, chemical, or 
biochemical processes and/or facilitated by the energy supplied externally. The regula-
tion of the drug release is controlled by the regulation of the applied process, or energy 
input [Yi,91]. 
Feedback-regulated drug delivery systems encompasses those DDSs activated by a 
triggering agent, such as a biochemical substance and regulated by its concentration via 
some feedback mechanisms. The drug delivery rate for this system is controlled by the 
concentration of the triggering agent [Yi,91]. 
Site-targeting drug delivery systems encompasses those DDSs that can attach them-
selves to specific target molecules. These target molecules are only present in certain 
locations, either by being organ specific, or by depending on the disease. These systems 
usually take use of the antigen antibody combination in order to lock their targets [Yi,91]. 
Although the use of DDSs shows promising properties, several challenges have to be 
solved before the use of any new DDS. These problems are mainly the design of a com-
patible drug reservoir compartment to both the drug and the body, the attachment of a 
rate-controlling element to the reservoir, or the implementation of the reservoir as the 
rate-controlling element itself, the control of the energy source, and the distribution of the 
DDS in the organism [Yi,91]. 
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2.3.2 Proposed localized drug delivery system  
This project focuses on the development of light activation modulated DDS. Our DDS is 
a scaffold made of a biophotonic glass loaded with a photocleavable molecule which is 
cleaved using green light.  
In order to be able to obtain the activation signal to the DDS, the signal has two possibil-
ities, either to come from the outside of the body or it has to be produced around the 
DDS. As shown in Fig: 2-10, green light cannot be used as the skin absorbs this wave-
length.  
 
Figure 2-10: Absorption spectrum of human skin [He,14]. 
NIR is the most appropriate wavelength to use to active the DDS through the skin. 980nm 
excitation was chosen for this study due to low absorption of 980nm radiation by the skin 
(Fig: 2-10). Therefore, our proposed DDS requires a two-step activation: as a first step, 
the proper modulation of the activation 980nm excitation passes through the skin into 
the implant location which is then converted into visible light to active the photocleavable 
molecule as illustrated in Fig: 2-11.  
 
Figure 2-11: Modified schematic of the proposed DDS from [Zh,17] 
The production of visible light can be approached in several different ways such as per-
manent luminescence, electroluminescence, thermoluminescence and photolumines-
cence. In order to properly control the drug dose, the permanent luminescence approach 
cannot be taken. Thermoluminescence would require large changes in the temperature 
in order to obtain signal. However, this temperature change would damage the surround-
ing tissue, discarding thermoluminescence as an option. From the two remaining 
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choices, this work focuses on photoluminescence for its lower invasiveness. Green emis-
sion will be obtained from the upconversion process.  
Therefore, the biophotonic glass will be B50 glass which will be prepared with Er3+ and 
Yb3+ ions in order to exhibit green upconversion under 980nm excitation. Different scaf-
folds were prepared in this study in order to fabricate a scaffold with strong green upcon-
version.  
 17 
 
3. MATERIALS AND METHODS 
3.1 Material’s preparation 
In this study, active scaffolds were prepared by adding Er3+ and Yb3+ ions in the B50 
glass and also by adding NaYF4: Yb3+, Er3+ nanocrystals in the B50 glass powder prior 
to sintering in order to prepare scaffolds with strong green upconversion under 980nm 
pumping to photocleave the molecules.  
 
3.1.1 Glass preparation  
The glass of investigation was 26.93(SiO2)-26.93(B2O3)-22.66(Na2O)-1.72(P2O5)-
21.77(CaO) (in mol%) and it is labeled B50. It was prepared using SiO2 (Umicore, 
99.99%), Na2CO3 (Honeywell, >99.5%), H3BO3 (Sigma Aldrich, >99.5%), CaCO3 (Alfa 
Aesar, 99%), and CaHPO4·2H2O (Sigma Aldrich, 98%). The glasses were made using 
the following heat cycle: First the mixed batch was placed inside the furnace at room 
temperature and heated up to 650ºC at a rate of 10ºC/min, for 10 min and then to 850ºC 
for 10 min for the decomposition the precursors. Finally, it was melted at 1250ºC for 
10min. After quenching, the glass was annealed at 400ºC for 6h to remove residual 
stresses from the quench.  
Nanocrystals with the composition NaYF4:Er3+, Yb3+ were mixed prior to the sintering with 
the B50 glass. The synthesis and properties of the nanocrystals can be found in [Ha,11] 
[Pa,16] [Hy,16] 
The Yb3+, Er3+ co-doped glasses were produced by adding Er2O3 and Yb2O3 in the B50 
glass. The composition of the glass was (1-x-y) 26.93(SiO2)-26.93(B2O3)-22.66(Na2O)-
1.72(P2O5)-21.77(CaO) – xEr2O3 – yYb2O3 with x varying between 0 and 0.03 and y be-
tween 0 and 0.08. The raw materials for the rare-earth ions were Er2O3 (Sigma Aldrich, 
>99%), and Yb2O3 (Sigma Aldrich, >99.9%). The melting procedure was the same than 
the one used for the melting of B50 glass.  
 
3.1.2 Scaffolds sintering 
Scaffolds were prepared using the porogen burn-off technique. After annealing, the 
glasses were crushed using planetary ball milling technique. This technique is a grinding 
method that uses balls as the grinding medium, as they get moved violently by external 
forces (rotatory) mechanically crushing the sample into fine powder. The balls motion as 
well as the powder size and shape distribution depend on operational conditions. Fig: 3-
1 shows the milling mechanism in a planetary ball mill [Mio,04] 
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Figure 3-1: Ball milling mechanism. [Mio,04] 
The system used in this study was FRITSCH PULVERISETTE 7 premium line Planetary 
Ball Mill under the following conditions: 
• ZrO2 balls and bowls. 
• 10 balls per bowl. 
• 10mm diameter balls. 
• 850rpm. 
Runs consisted in the following cycle: 2-minute milling + 1 minute cool down + 2 minute 
milling. 
The Grinded powder was shorted by size using sieves. To properly control the particle 
size distribution, two different sizes of the sieve were used, one with the desired maxi-
mum particle size (38µm) and one intermediate size (150µm) to separate big fragments 
from the rest of the glass powder. The system used for the sieving was Retsch analytical 
sieve shaker AS200 Basic. 
The crushed powder was mixed with the porogen, NH4HCO3 (Sigma Aldrich, >99.5%) at 
a 0.3/0.7 (glass/porogen) ratio. This mixture was shaped into a cylindrical shape with a 
diameter of 15mm. The powder was pressed under 20GPa. The pellets were sintered at 
300ºC using a rate of 1ºC/min to allow the decomposition and evaporation of the poro-
gen. After reaching 300ºC, the heating rate was increased to 5ºC/min to reach the sin-
tering temperature. The sintering was for one hour. After sintering, the scaffolds were 
stored in a desiccator. The sintering temperature depended on the glass composition: 
567ºC was used to sinter the Er3+, Yb3+ codoped scaffolds and 550ºC to sinter the parti-
cles containing scaffolds and the undoped scaffolds. 
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3.1.3 Photocleavable molecules 
In this study, a photoswitchable molecule was tested as a proof of concept for photo-
cleavable molecular structures. The chosen molecule was Phthalimide-Azo-Iperoxo 
(PAI) (Fig: 3-2). 
 
Figure 3-2: PAI photoswitchable molecule [Ri,19]. 
This molecule shows a trans-cis isomerism and exhibits photoswitching when exposed 
to the proper radiation. When the molecule is exposed to 365nm radiation, the molecule 
is promoted to change into the meta stable cis-Pai isomer, while irradiation at 460nm 
promoted the reversion into the more stable trans-Pai isomer [Ri,19] as seen in the ab-
sorption spectra of trans and cis isomers displayed in Fig:3-3. 
 
Figure 3-3: Absorption spectra of PAI after different irradiation (a)  
and absorbance over several irradiation cycles (b) [Ri, 19] 
Fig: 3-3 b shows that photoswitching can be repeated for several cycles without notice-
able photofatigue. [Ri,19] 
 
The photocleavable molecules were provided by Dr. Rossella Castagna from Institute 
for Bioengineering of Catalonia (Spain).  
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3.2 Material’s properties  
3.2.1 Physical properties 
The density was measured using Archimedes’ principle. The immersion liquid ethanol 
was used, and the measurements were performed at room temperature. The mass of 
the sample was measured in air and then when immersed in Ethanol. The density of the 
glass was then calculated using the Eq.1:  
𝜌 = 𝜌𝑒𝑡ℎ𝑎𝑛𝑜𝑙 ⋅
𝑤𝑎𝑖𝑟
(𝑤𝑎𝑖𝑟 − 𝑤𝑒𝑡ℎ𝑎𝑛𝑜𝑙)
 
Where ρ is the sample density, ρethanol is the density of ethanol at measured temperature, 
wair is the weight of the sample in air and wethanol is the weight of the sample in ethanol. 
The equipment utilized was OHAUS Adventurer Analytical scale and the corresponding 
kit to calibrate the equipment before measuring the samples. The density is measured 
with an accuracy of ±0.02g/cm3. 
 
3.2.2 Thermal properties  
The thermal properties were analyzed by differential scanning calorimetry (DSC) using 
449 F1 Jupiter (Netzsch-Gerätebau GmbH,Selb,Germany) equipment. Samples were 
measured by placing 30mg sample (powder form) in a Pt pan. Their heat absorption was 
compared to that of a reference Pt pan of similar mass while keeping sample and refer-
ence at the same temperature and while increasing the temperature at a constant rate 
of 10ºC/min. 
 
Figure 3-4: Thermogram of a glass.[Ro,18] 
From the DSC curve (Fig: 3-4), several important information can be obtained such as 
the glass transition temperature (Tg), the crystallization temperatures (temperature onset 
[1] 
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of the crystallization peak (Tx), and crystallization peak temperature (Tp)). Tg was defined 
as the inflection point in the thermogram and Tp at the maximum of the crystallization 
peak. The precision of these temperatures is given at 3ºC. Another important parameter 
is ΔT, which is defined as the difference between Tx and Tg and is related to the thermal 
stability of the glass against crystallization. The resolution of this temperature window 
span is of 6 ºC. 
Other significant parameters can be obtained, such as specific heat by measuring the 
slope of the curve or phase transformation latent heat by measuring the areas under/be-
low the phase transformation peaks. 
 
3.2.3 Optical properties  
The absorption spectra were measured using UV-3600 Plus UV-VIS-NIR Spectropho-
tometer Shimadzu. This device, the schematic of which can be found in Fig: 3- 5, pro-
duces polychromatic light from a lamp (or several different ones), and passes this light 
through a monochromator resulting in the selection in a narrow bandwidth of the source 
spectrum. The “monochromatic” light is divided by a beam splitter (50/50) and the two 
resulting beams are passed through both the sample and a reference. The transmitted 
light is then collected and measured by a detector. 
 
Figure 3-5: Schematic of a double beam spectrophotometer [Je,15] 
The spectrometer sweeps through the required wavelength range adjusting the mono-
chromator and the source lamps and calculates the absorbance at a specific wavelength 
by the comparing the intensity from the reference and the sample. This measurement 
allows the obtention of the absorbance spectrum of the material, which is helpful to cal-
culate the absorption coefficient and cross-section, two parameters which are intrinsi-
cally related to the ions site in the glass, and ultimately to the glass photonic properties. 
The Beer–Lambert Law (Eq.2.) relates the absorbance (A) with the transmitted and in-
coming intensities (IT, I0) and the material’s thickness (t) and absorption coefficient (α). 
𝐴 = − 𝑙𝑜𝑔10
𝐼𝑇
𝐼0
= ∫ 𝛼  𝑡 𝑑𝑡  [2] 
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The absorption cross-section (σ) is related to the absorption coefficient and the number 
of ions per unit volume (N) by Eq.3.: 
𝜎 =  
𝛼 
𝑁
 
 
3.2.4 Spectroscopic properties  
The up-conversion emission spectra in the 350-800nm range were measured using a 
Jobin Yvon iHR320 spectrometer (Horiba Jobin Yvon SAS, Unterhaching, Germany) 
equipped with a Hamamatsu P4631-02 detector (Hamamatsu Photonics K.K., Hamama-
tsu, Japan) and a filter (Thorlabs FEL 1500, Thorlabs Inc., Newton, NJ, USA). Emission 
spectra were obtained at room temperature using an excitation monochromatic source 
at 976 nm, emitted by a single-mode fiber pigtailed laser diode (CM962UF76P-10R, 
Oclaro Inc., San Jose, CA, USA). 
Emission is due to the relaxation of the electrons in the high energy states by radiative 
routes. The radiative relaxation routes emit photons that are collected by a detector. By 
placing a monochromator in the optical path between the sample and the detector, the 
emission at each specific wavelength can be detected, giving information of the emission 
spectrum of the sample. 
Up conversion is based on multiphoton processes, where an already excited electron is 
further excited by a second photon before relaxing radiatively emitting a photon of higher 
energy than the absorbed ones as illustrated in Fig: 3-6, taken Yb3+, Er3+ codoping as an 
example.[Pa,16] 
 
Figure 3-6: Schematic of upconversion, and proposed upconversion  
mechanism between Yb3+ and Er3+.[Pa,16]  
 
[3] 
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3.2.5 Mechanical properties  
The mechanical properties of the scaffolds were tested in compression using In-
stron8800 equipment. 
Standard compression testing was performed by compressing the scaffolds and record-
ing the applied load and the displacement as a function of time. From this data, the en-
gineering Stress-Strain (σ-ε) curve was obtained, and from it, the compressive strength 
of the material can be determined.  
The typical σ-ε curve of a highly porous linear elastic ceramic is shown in Fig: 3-7a:  
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Figure 3-7: σ-ε curve of highly porous ceramic [Al,12] (a) and of B50 + 1.5%NCs (b) 
 The typical σ-ε curve exhibits three different regions  
- a first linear region, that showcase the elastic behavior of the material,  
- a plateau region, that is related to the collapse of the porous structure  
- a final non-linear increasing region that is related to the compression of the col-
lapsed powder. 
The only focus of the study of this project is the initial linear regime, where only elastic 
recoverable deformations take place, and the compressive strength given in this thesis 
the stress value measured of the plateau strength.  
The σ-ε curve of a scaffold prepared with the NaYF4 nanocrystals, taken as an example 
is shown in Fig: 3-7b. The elastic regime can be attributed to deformations around 30%, 
measuring a compressive strength of (2.9±0.3) MPa, the minimum and maximum values 
are displayed in red and blue respectively. Moreover, the lack of plasticity of the glass 
can be seen from the lack of the plastic yielding plateau. 
 
3.2.6 Porosity measurement 
Porosity was estimated by measuring the volume of the cylindrical scaffold and its mass, 
obtained from the density using the Eq 4. 
𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦(%) = 1 −
ρ𝑎𝑝
ρ𝑡ℎ
 =  1 −
𝑚
𝜋𝐷2⁄
ρ𝑡ℎ
 
a) 
b) 
[4] 
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3.2.7 In vitro testing 
Glass scaffolds were immersed in simulated body fluid (SBF) following a mass to volume 
ratio of 10ml per 100mg for 24, 48, 72, 168, and 336 h at 37 oC in an incubating shaker 
(INFORS Multitron II). Three parallel samples were taken for each composition and time 
point. In the incubator, the orbital speed of 100 RPM was chosen to provide laminar flow 
mixing of the solution without altering the dissolution process by particle movement.  
The change in the pH over time for the buffering solution was recorded for each immer-
sion time and the average and standard deviation of the triplet was calculated. The pH 
was then compared to that of a blank sample which contains only the buffer. The equip-
ment used was Mettler Toledo SevenMulti MP 225 pH-meter, and it shows a resolution 
of ±0.02. After testing, the scaffolds were washed by acetone and dried for their weigh-
ing. 
 
3.2.8 X-ray diffraction analysis 
XRD is a technique that gives information about the crystalline structure of a material by 
irradiating the sample with x-rays. XRD can be used to determine if a material is either 
amorphous or crystalline. 
This technique is based on Bragg’s diffraction law (Eq.5), and is sketched in Fig: 3-8: 
2 ∗ 𝑑 ∗ 𝑠𝑖𝑛(𝜃) = 𝑛 ∗ 𝜆 
Where d is the inter planar distance, θ is the incidence angle, n is any positive integer 
and λ is the wavelength of the x-ray. 
 
Figure 3-8: Sketch of XRD working principle [Ph,13] 
The principle dictates that diffracted light interferes constructively only when the above 
expression is fulfilled, implying that the effective distance between crystalline planes to 
be travelled by the photons is equal to a multiple of the half wavelength [Wi,06].  
The spectrum of any material is characteristic and most known crystalline materials have 
already been identified and tabulated. [Ch,01]. This allows the proper identification of 
any crystalline phase in the sample. 
[5] 
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The measurements were carried out using Panalytical EMPYREAN multipurpose X-Ray 
Diffractometer equipment with Fe filtered Co-kα radiation and a θ-2θ configuration. Fol-
lowing the schematics shown in Fig: 3-9.  
 
Figure 3-9: XRD set up in a θ-2θ configuration (fixed x-ray source) [Ep,16]. 
X-rays are generated in the X-ray tube by impinging high energy electrons and emitting 
at the characteristic wavelength of the source material. The produced X-rays are filtered 
from unwanted lines and focused on the sample’s surface. The diffracted X-rays are 
collected by the detector. The X-ray tube is fixed in position while the sample stage and 
the detector rotate in a θ-2θ configuration to sweep most geometrical configurations. 
 
3.2.9 Scanning electron microscope  
Scanning electron microscope (SEM) is a powerful microscopy technique that uses elec-
trons to obtain resolutions down to the nanometer scale. 
The operating principle of SEM is to generate and accelerate electrons to high energies 
by a potential difference and focusing them into the sample. The electrons interact with 
the sample emitting different signals such as back scattered electrons (BSEs), second-
ary electrons (SEs) and X-rays. The interaction is confined to a small volume at the im-
pingement zone. The studied area is swept by the beam point by point recording the 
information as if a pixel image was taken. This allows for the reconstruction of the sam-
ple’s surface while providing some compositional information.  
In SEM, the main signals are BSEs and SEs, these two signals are not collected simul-
taneously, and image usually only use one of them.  
- SEs provide better topological contrast and is desired for its higher resolution.  
- BSEs are very sensitive to the atomic number of sample’s atoms, providing high 
compositional resolution. 
The schematic of a SEM can be observed in Fig: 3-10. 
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Figure 3-10: Schematics of a SEM [Go,12]. 
Currently most SEMs are equipped with an energy dispersion spectroscopy (EDS). This 
system uses the X-rays generated by the interaction between the electrons and the sam-
ple to analyze the elements present in the sample in a quantitative manner. When the 
electrons from the beam excite the atoms in the sample, they move their electrons to 
higher metastable energy levels, from which they relax, emitting X-rays of a characteristic 
energy. These energies depend only on the element and the excitation. The EDS system 
collects and analyzes the generated X-rays producing a spectrum. In this spectrum, the 
characteristics peaks from the elements present in the sample can be observed together 
with a background radiation produced by inelastic interactions between the electrons and 
the sample. It is possible to produce a quantitative evaluation of the elemental composi-
tion in different areas of the sample with a resolution about one mole percent [Go,12]. 
Fig: 3-11 shows a typical EDS spectrum. 
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Figure 3-11: Typical EDS spectrum [Go,12] 
EDS can be performed in line or mapping mode. These modes perform several individual 
point analyses (usually with lower capture times, reducing resolution) covering a whole 
line/area providing elemental information, and the variation through the investigated 
space. 
The equipment used in this study was Carl Zeiss Crossbeam 540, with a Oxford Instru-
ments X-MaxN 80.EDS detector. 
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4. RESULTS AND DISCUSSION 
The main purpose of this study is to produce a NIR sensitive drug delivery system using 
photocleavable molecule. The objective of this study was the preparation of biphotonic 
scaffolds which not only are bioactive but also exhibit green emission under 980nm 
pumping to photocleave the photosensitive molecule after implantation in the body. 
 
4.1 Preparation and characterization of scaffolds 
In this study, the scaffolds were prepared using the burn off technique. At first, the glass 
is prepared using standard melting process, then crushed into powder and finally sin-
tered. The glass of investigation is the borosilicate glass with the composition 26.93 SiO2-
26.93 B2O3-22.66 Na2O-1.72 P2O5-21.77 CaO (in mole %) (Referred as B50). This glass 
was reported to be optimal for producing amorphous scaffolds while allowing hydroxy-
carbonate apatite precipitation within the scaffold structure [Fa,17]. 
In order to obtain green emission from the scaffolds using 980 nm pumping, the B50 
glass was prepared with Yb3+ and Er3+ ions. In this study, two series of scaffolds were 
fabricated:  
- the Yb3+ and Er3+ ions were added in the glass batch prior to the melting. The 
scaffolds are labeled as Yb3+, Er3+ doped scaffolds 
- NaYF4:Yb3+, Er3+ nanocrystals (NCs) with strong green upconversion under 
980nm pumping were added in the glass crushed into powder prior to the sinter-
ing. These scaffolds are labeled as NCs scaffolds 
 
4.1.1 Yb3+, Er3+ doped scaffolds 
4.1.1.1 Optimization of the Er2O3 and Yb2O3 content 
The scaffolds were prepared from Yb3+, Er3+ codoped borosilicate glasses. The concen-
tration of Yb3+ and Er3+ had to be first optimized in order to prepare borosilicate scaffolds 
with strong green upconversion. Below is the picture of the glasses prepared with various 
Yb3+ and Er3+ content (Fig: 4-1).  
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Figure 4-1: Picture of the borosilicate glasses prepared with different Er2O3-Yb2O3 con-
tents (mole %)  
While an increase in Yb2O3 content has no impact on the color of the glasses, an increase 
in Er2O3 leads to a darker pink coloration of the glasses 
The density and thermal properties of the glasses are listed in Table 1.  
Table 1: Density and thermal properties  
Sample 
[Er2O3 -Yb2O3] 
[mole %] 
ρ  
(g/cm3) 
[±0.02g/cm3] 
Tg 
(ºC) 
[±3ºC] 
Tx 
(ºC) 
[±3ºC] 
ΔT 
(ºC) 
[±6ºC] 
0-0 2.62 517 604 87 
0.5-1 2.79 524 614 91 
0.25-2 2.91 524 615 99 
0.5-2 2.88 525 619 89 
0.25-4 3.08 528 623 91 
0.5-4 3.13 529 624 95 
1-4 3.18 533 624 108 
1.5-4 3.24 534 623 90 
3-4 3.39 536 635 87 
0.5-8 3.58 541 641 94 
3-8 3.79 549 653 104 
 
One can notice that ΔT, the gauge of crystallization, is > 80ºC independently of the glass 
composition indicating that all glasses are good glass formers and so good candidates 
for the sintering process. No crystallization is expected to occur during the sintering pro-
cess. 
The density of the glasses as a function of the rare-earth (RE) content can be found in 
Fig: 4.2 
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Figure 4-2  Density as a function of Er2O3 (a), Yb2O3 (b) and total RE content (c) 
As observed in Fig: 4.2.a and b, an increase in the content of the RE ions in the glass 
increases the glass’ density linearly. And as displayed in Fig: 4.2.c, the effect of both 
RE’s ions has similarly strong effect on the increase in the density. This can be attributed 
to the addition of heavy ions increasing similarly the average density. 
The thermal properties of the glasses as a function of the RE content can be found in 
Fig: 4.3 
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Figure 4-3: Tg (a) an Tx (b) as a function of Er2O3 and Yb2O3 content 
While the progressive addition of Er3+ has no significant impact on Tg and Tx, it is the 
progressive addition of Yb3+ which increases Tg and Tx.  
The absorption spectrum of the 0.5-4 glass, taken as an example, is shown in Fig: 4.4 
a) b) 
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Figure 4-4: Absorption spectrum of the 0.5-4 glass. 
The UV‐Vis absorption spectrum on Fig: 4-4 exhibits multiple absorption bands related 
to the 4f-4f transitions of Er3+.from the ground state to the different excited levels. The 
absorption band at 980nm can also be related to the 4f-4f transition of Yb3+. 
The absorption coefficient and cross-sections of the investigated glasses are presented 
in Table 2.  
Table 2: Absorption coefficients and cross-sections of the investigated glasses 
Sample 
[Er2O3%-
Yb2O3%] 
[Er3+] 
(1020 
ion.cm-3) 
[±4%] 
[Yb3+] 
(1020 
ion.cm-3) 
[±4%] 
α  
(975nm) 
(cm-1) 
α 
(1534nm)  
(cm-1) 
σabs 
(975nm)  
(10-21cm2) 
[±10%] 
σabs 
(1534nm) 
(10-21cm2) 
[±10%] 
0.5-1 2.45 4.90 5.84 1.38 7.94 5.63 
0.25-2 1.23 9.87 10.19 0.71 9.18 5.76 
0.5-2 2.41 9.66 11.24 1.54 9.31 6.39 
0.25-4 1.20 19.17 14.48 0.71 7.11 5.90 
0.5-4 2.40 19.23 16.42 1.38 7.59 5.74 
1-4 4.79 19.14 17.80 2.81 7.44 5.86 
1.5-4 7.17 19.12 16.62 4.07 6.32 5.67 
3-4 14.18 18.90 15.66 7.99 4.73 5.64 
0.5-8 2.35 37.64 16.82 1.32 4.21 5.60 
3-8 13.75 36.66 34.35 8.01 6.81 5.83 
 
As expected, an increase in the Er2O3 and Yb2O3 content leads to an increase in the 
absorption coefficient at 975nm while the increase in the Er2O3 content increases the 
absorption coefficient at 1534nm. 
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The absorption cross-sections are similar to the absorption cross-section of silicate 
glasses reported in [Fe, 10]. One can notice that the absorption cross-section at 1534 
nm is independent of the RE content in the glass, suggesting that the Er3+ ions are lo-
cated in the same sites in the investigated glasses .However, the absorption cross-sec-
tion at 980nm depends on the RE content indicating that most probably the Yb3+ ions 
suffer changes in its electronic environment when the amount of rare-earth ions in-
creases.  
The upconversion spectra of the glasses were measured using 980nm pumping and 
some of the spectra are presented in Fig:  4-5.  
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Figure 4-5: Up conversion spectra of selected glasses. 
The spectra exhibit bands 526, 540 and 660nm which can be correlated to 2H11/2 → 4I15/2, 
4S3/2 → 4I15/2 and 4F9/2 → 4I15/2 transitions of Er3+ ions, respectively [Br,93],[Li,08]. Unfor-
tunately, the intensity of the red emission is larger than that of the green emission. None-
theless, the glasses exhibit green upconversion. Additionally, one can notice that an in-
crease of Er2O3 and Yb2O3 content from 0.25 to 0.5 and 2 to 4, respectively, increases 
the intensity of the upconversion. However, when the Er2O3 and Yb2O3 content further 
increase, the intensity of the upconversion decreases. As reported [Ti,12], the decrease 
in the intensity of the upconversion with an increase in the content of the rare-earth ions 
can be due to Er3+ concentration quenching, the energy transfer between Er3+ ions de-
populating the thermalized levels 4S3/2, 2H11/2 and the level 4F9/2 of Er3+. 
As a summary: due to its large intensity of the upconversion, the glass with 0.5 mol% of 
Er2O3 and 4 mol% of Yb2O3 (labeled at 0.5-4 glass) was chosen for the fabrication of the 
scaffold.  
 
4.1.1.2 Fabrication and characterization of the Yb3+, Er3+ doped scaffolds  
To be considered as promising scaffolds, the scaffold should be possessed with a po-
rosity of at least 65% and a compressive strength of 2-12MPa to be similar to that of 
cancellous bone [Fu,11]. The width of the bracket of possible values is due to the inherit 
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fluctuation of biological tissue, having properties that depend widely on the patient con-
dition (age, fitness, sickness) and the specific bone. 
The Yb3+, Er3+ doped scaffolds were sintered as explained in Chapter 3. The porosity of 
various scaffolds is shown in Fig: 4-6.  
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Figure 4-6: Porosity values of the different Yb3+, Er3+ codoped scaffolds. 
Fig: 4-6 shows that scaffolds were successfully prepared with an average value of 
71.42% porosity with a standard deviation of 0.87%.  
Fig: 4-7 shows the compressive strength curve of one of the doped scaffolds showing 
that the compressing strength for this sample is ~0.9MPa.  
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Figure 4-7:  Compressive strength curve of a doped scaffold 
The measurement was repeated for all scaffolds and the average compressive strength 
is estimated at (0.85 ±0.18) MPa which is lower compared to B50 scaffold measured at 
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2.5MPa for 50% porosity [Fa,17]. This reduction in the compressive strength should be 
related to different porosities of the scaffolds. However, one should point out that the test 
performed here is not reliable due to the poor sample preparation (parallelization and 
polishing of the scaffolds). The measurements should be repeated. Nonetheless, the 
scaffolds possess suitable porosity and acceptable level of mechanical properties.  
The upconversion spectra of the scaffolds were measured in different areas in a scaffold 
and in different scaffolds in order to check the homogeneity of the upconversion intensity 
within one scaffold and between the scaffolds. The upconversion spectra are shown in 
Fig: 4-8a. 
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Figure 4-8: Upconversion spectra of scaffolds (a) and of the glass prior to and after sin-
tering. (b) 
As shown in Fig: 4.8a, the scaffold exhibits uniform intensity of upconversion when meas-
ured in different parts of the scaffold. One can also notice the good homogeneity in the 
intensity of the upconversion between the scaffolds confirming that it is possible to pro-
cess a large number of scaffolds with homogenous upconversion. As compared to the 
data presented in Fig: 4-5, the signal is noisier due to lower intensity of upconversion. 
This is due to the lower amount of glass (and so to the amount of RE) when performing 
the measurement on the porous scaffolds. As shown in Fig: 4.8b, the upconversion spec-
trum is modified after the sintering process indicating that the sites of Er3+ change after 
sintering.  
In order to understand the changes in the upconversion spectra, the XRD pattern of the 
scaffold was measured and can be found in Fig: 4-9.  
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Figure 4-9: XRD pattern of the Yb3+, Er3+ doped scaffold 
Surprisingly, sharp peaks with small intensity can be seen in the Yb3+, Er3+ doped scaffold 
revealing the presence of crystals in the scaffolds, the identification of which is still in 
progress. It is maybe the partial crystallization of the scaffolds which leads to changes in 
upconversion properties. The partial crystallization of the Yb3+, Er3+ doped glass during 
sintering is not understood as this glass was found to be thermally stable.  
 
4.1.2 Scaffold preparation with NaYF4: Yb3+, Er3+ nanocrystals 
Scaffolds with NaYF4: Yb3+, Er3+ nanocrystals (NCs) were also fabricated using the sin-
tering process by adding the NCs in the glass crushed into powder prior to sintering.  
At first, the amount of the NCs was optimized in order to tailor the amount of NCs to 
process scaffolds with strong upconversion while possessing the required properties 
listed in the previous section. The porosity and the mechanical properties of the scaffolds 
prepared with different weight % of the NCs are shown in Fig: 4.10. 
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Figure 4-10: Porosity and compressive strength curve of NCs containing scaffolds. 
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An increase in the amount of NCs decreases the porosity of the scaffold and so increases 
the compression strength. As expected, the intensity of the conversion was found to in-
crease as the amount of NCs increases. We also found out that it is difficult to prepare 
scaffolds with homogeneous upconversion when adding the NCs in low amount. There-
fore, the amount of NCs was fixed at 2wgt%. The scaffolds have a porosity of (57,4 ± 
4.9) %. Due to their low porosity, the scaffolds have a compressive strength of (3.9 ± 1.1) 
MPa which is higher than that of the measured in the B50 scaffolds.  
The up-conversion spectra of the NCs containing scaffolds were measured. The upcon-
version spectra of the as-prepared NCs and of the NCs containing scaffolds are pre-
sented in Fig: 4-11.  
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Figure 4-11: Comparison between up conversion spectra of  
NC containing scaffolds before and after sintering 
It is clearly shown that the sintering process has an impact on the upconversion spec-
trum.  
In order to understand this result, all intermediate sintering states were individually tested 
(heat treatment & grinding) for the nanocrystals alone and the results are displayed in 
Fig 4-12.  
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Figure 4-12 NCs alone UC spectrum prior to and after sintering 
Fig 4-11 shows that both heat treatment and mechanical grinding lead to a reduction in 
the up-conversion emission of the nanocrystals with an increase of the red to green ratio. 
This could be attributed to a change in the crystalline structure of the nanocrystals pro-
moted by the external energy applied, changing from hexagonal to high temperature 
cubic phase as reported in [Ha,11], [Hy,16]. However, in our study, the sintering temper-
ature is too low to induce any changes in the crystalline structure. It is possible that the 
decrease in the upconversion after sintering is related to the thermal activation of the 
deleterious thermal phonons from host lattice, internal/surface crystalline defects and 
surface chemical bonds in agreement with [Ya,19]. The grinding is then expected to cre-
ate inter defects which might cause the intensity of the upconversion to decrease. 
The XRD pattern of the NCs containing scaffold which contains 10wgt% of NCs is dis-
played in Fig 4-13. 
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Figure 4-13 XRD pattern of the 10wg% NCs containing scaffolds and of the NCs alone 
The XRD pattern of the NCs containing scaffold shows peaks which can be related to 
the NCS. However, as seen in Fig: 4-13, additional peaks can be observed indicating 
the presence of additional crystals in the glass as seen for the doped scaffolds.  
The NCs scaffolds were investigated under SEM to verify how the NCs are distributed in 
the scaffold. Fig: 4-14 shows the SEM pictures of the NCs containing scaffold which 
contain 2wgt% of NCs.  
 
Figure 4-14: SEM pictures of the NCs scaffolds:  
As shown above, the NCs are agglomerated with a size of 500-1000nm. The agglomer-
ates were found to be well dispersed. No crystals could be seen using SEM. 
The elemental mapping can be found in Fig: 4-15.  
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Figure 4-15: SEM image (a) and elemental EDS mapping (b) of the NCs containing 
scaffold 
The elemental mapping allowed one to see clearly the NCs. The composition around the 
NCs is homogeneous. No crystals could be suspected neither from the elemental map-
ping.  
 
4.2 Photocleavage of molecules using NIR pumping 
In this section, we first present the in-vitro testing of the newly developed scaffolds and 
then the preliminary results of the photocleavage of molecules using UV and green light. 
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4.2.1 In vitro testing 
The different scaffolds were tested in vitro using simulated body fluid (SBF), for up to 2 
weeks. During incubation the samples were placed in a shaking incubator (120 RPM), at 
37ºC. The SBF/glass ratio used for the experiments was 10mL/100mg. 
The mass loss of the scaffolds and the change of pH in the SBF were measured over 
time and their results are summarized in Fig: 4-16. 
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Figure 4-16: pH of the immersion solution (a) and scaffolds mass loss (b) of as a func-
tion of immersion time of in SBF. The undoped scaffolds are labelled as “B50”, the Er3+, 
Yb3+, codoped scaffolds as “Doped”, and the NaYF4: Yb3+, Er3+ nanocrystals containing 
scaffolds as “NCs”. A blank sample (only SBF) is also displayed, to show the variation 
in pH of the buffering solution, as a function of incubation time. 
The pH of the solutions which contains the scaffolds increases overtime due to the re-
lease of alkaline and alkaline earth ions from the glass to the solution increasing the 
basicity of the solution [Se,00] [He,06].One can notice that the solutions with the newly 
developed scaffolds (doped and NCs) have lower pH than the solution which contains 
the well-known B50 scaffold although the glass matrix to prepare the scaffolds is the 
same.  
In Fig: 4-16 (b), a similar behavior can be observed: the mass loss increases with im-
mersion time in SBF and can be related to the dissolution rate [Hu,06]. The newly devel-
oped scaffolds exhibit a smaller mass loss than the reference B50 scaffold indicating that 
they possess a slower dissolution rate than the reference B50 scaffold. It is clearly shown 
that the addition of Er3+ and Yb3+ in the glass reduces more the dissolution rate of the 
glass than adding the NCs in the glass. This may be due to the partilar crystallization of 
the scaffolds and/or to the different glass structures, clearly showing the need to investi-
gate the structure of the glass.  
 
4.2.2 Drug released using 980nm excitation 
The possibility of the scaffolds to promote changes in an organic molecule was tested 
using Phthalimide-Azo-Iperoxo (PAI). This molecule shows a trans-cis isomer reversible 
switching promoted by light interaction:  
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- when irradiated with high energy photons (peak absorption at 315nm), the trans 
to cis switching is promoted,  
- when irradiated with photons of lower energy (green light), the cis to trans switch-
ing is promoted.[Ri,19] 
The trans-cis switch can be tracked from the changes in the absorption spectrum of the 
molecules. 1mg of the molecule was diluted in 42.6ml of SBF and placed in a quartz 
cuvette.  Fig: 4-17 presents the absorption spectrum of the as-prepared solution.  
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Figure 4-17: Absorption spectrum of as received PAI molecule 
The absorption spectrum exhibits 2 absorption bands at 319 and 426 nm which can be 
related to trans and cis isomerism, respectively.  
The switching of the molecule was tested using a 365nm UV lamp. The solution was 
irradiated from the top and from the side of the cuvette for 5min to few hours and the 
absorption spectra are shown in Fig: 4-18a and b, respectively. 
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Figure 4-18: Absorption spectrum of PAI solution in SBF irradiated with UV lamp from 
the top (a) and from the side (b) 
(b) (a) 
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As shown above, it is possible to reduce the intensity of the band at 319nm, related to 
trans, using UV lamp. The irradiation is more efficient when irradiating the cuvette from 
the side. Therefore, it is possible to reduce by 25% the intensity of the absorption band 
when irradiating from the side for 1 hour.  
The solution was also irradiated with a green laser pointer. The absorption spectrum was 
measured after 5 and 15min irradiation.  
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Figure 4-19 Absorption spectrum of PAI solution in SBF after irradiation with green light  
An increase in the intensity of the absorption band at 319nm increases after green irra-
diation, as shown in Fig:4-19, this increase is larger when the duration of the green irra-
diation is longer. This clearly shows that the green laser pointer can be used to convert 
back the molecule to trans isomerism. 
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5. CONCLUSIONS 
In this work, new biophotonics scaffolds have been developed so they can be used as 
an externally controlled localized drug delivery system (DDS) when loaded with photo-
chromic drug. The glass of investigation was the well-known B50 bioactive glass in which 
Er3+ and Yb3+ ions were added to add some luminescence properties. In this study, two 
different approaches were used to fabricate: the scaffolds were prepared by adding the 
RE ions in the glass and scaffolds were prepared with the upconverter NaYF4: Yb3+, Er3+ 
crystals. We clearly showed that it is possible to prepare these scaffolds with proper 
porosity, acceptable compression strength and green upconversion. However, crystalli-
zation was found to occur during sintering. In vitro testing of the scaffolds has been pro-
duced and compared to the base B50 biocompatible glass, and the results were into 
acceptable range. The active scaffolds were found to have a slower dissolution rate than 
the B50 glass probably due to the partial crystallization and/or to different structures of 
the scaffolds. A photoswitchable molecule was characterized to be used as a sensor and 
trigger of the drug release in the DDS. 
 
Next steps to be made in the scope of this project: 
Due to the outbreak of the COVID-19 pandemic, and the resulting closure of university 
facilities, the following measurements couldn’t be performed  
• Mechanical properties characterization of doped scaffolds should be measured  
• Mechanical properties characterization of scaffolds after immersion should be 
measured. 
• Crystalline phases identification in scaffolds: A throughout investigation of the 
different crystalline phases present in the newly developed scaffolds should be stud-
ied to understand how to suppress the formation of crystalline phases. The recom-
mended procedure would be a complete analysis of the XRD spectrum, to proper 
identify all peaks. 
• Up conversion measurement of the immersed scaffolds: The upconversion lumi-
nescence of the immersed scaffolds should be measured and compared to that of the 
samples prior to immersion to confirm that the scaffolds still exhibit green upconver-
sion while being covered by the hydroxyl apatite layer forming during the immersion 
in SBF. 
• Ion release during SBF immersion: Samples from the incubation of scaffolds in SBF 
have been stored in the refrigerator for ICP measurements, in order to identify the 
ions present in the solution and their concentrations. This experiment would provide 
useful information about the biocompatibility and degradation rate of the scaffolds. 
• Activation of the photoswitchable molecule with the upconverter scaffolds: a 
proper characterization of the upconverter scaffolds loaded with the photoswitchable 
molecule solution should be performed to check if the green upconversion from the 
scaffolds could be used to photocleave the molecule. 
With these measurements, we expect to be able to identify which scaffold is the most 
promising to be used as a DDS.  
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Next steps outside of the scope of the project 
• Creation of a light sensitive drug reservoir: The main idea of the project relies on 
the ability of breaking the surface layer of a sensitive drug reservoir using light. One 
of the main challenges of this project is the fabrication of said reservoir. As the skills 
required for this step are different to those of the rest of the study, this part is left for 
a future collaboration with a chemistry center research group. 
• Optimization of the material combination and production methods: This thesis 
purpose was to prove the concept, but a better optimization of the photosensitive 
molecule and upconverter pair should be performed to better match the absorb-
ance/emission spectra of each other, to provide a more efficient cleavability of the 
drug reservoir.  
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